Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 4 studies | 18% ± 2% | |
| epithelial cell | 3 studies | 30% ± 8% |
Insufficient scRNA-seq data for expression of PDRG1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1024.29 | 1445 / 1445 | 100% | 25.78 | 183 / 183 |
| ovary | 100% | 826.47 | 180 / 180 | 100% | 44.11 | 430 / 430 |
| skin | 100% | 983.09 | 1808 / 1809 | 100% | 45.64 | 472 / 472 |
| brain | 100% | 1140.13 | 2637 / 2642 | 100% | 52.65 | 705 / 705 |
| uterus | 100% | 916.39 | 170 / 170 | 100% | 64.56 | 458 / 459 |
| thymus | 100% | 981.03 | 653 / 653 | 100% | 36.17 | 603 / 605 |
| adrenal gland | 100% | 1091.82 | 258 / 258 | 100% | 45.24 | 229 / 230 |
| liver | 100% | 681.06 | 226 / 226 | 100% | 30.01 | 404 / 406 |
| kidney | 100% | 1095.63 | 89 / 89 | 99% | 29.24 | 896 / 901 |
| pancreas | 99% | 495.26 | 326 / 328 | 100% | 36.52 | 178 / 178 |
| stomach | 100% | 701.45 | 359 / 359 | 99% | 50.35 | 284 / 286 |
| prostate | 100% | 1104.33 | 245 / 245 | 99% | 39.80 | 498 / 502 |
| breast | 100% | 1037.46 | 459 / 459 | 99% | 60.69 | 1109 / 1118 |
| intestine | 100% | 912.37 | 966 / 966 | 99% | 55.08 | 522 / 527 |
| bladder | 100% | 923.57 | 21 / 21 | 99% | 58.46 | 499 / 504 |
| lung | 99% | 726.85 | 575 / 578 | 99% | 42.80 | 1145 / 1155 |
| adipose | 100% | 812.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 65.00 | 29 / 29 |
| spleen | 100% | 1180.91 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 50.54 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 22.78 | 1 / 1 |
| blood vessel | 100% | 873.23 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 792.33 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 634.25 | 855 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 30.74 | 79 / 80 |
| peripheral blood | 92% | 661.12 | 859 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006457 | Biological process | protein folding |
| GO_0050821 | Biological process | protein stabilization |
| GO_0101031 | Cellular component | protein folding chaperone complex |
| GO_0016272 | Cellular component | prefoldin complex |
| GO_1990062 | Cellular component | RPAP3/R2TP/prefoldin-like complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0051082 | Molecular function | unfolded protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PDRG1 |
| Protein name | p53 and DNA damage-regulated protein 1 |
| Synonyms | PDRG C20orf126 |
| Description | FUNCTION: May play a role in chaperone-mediated protein folding. . |
| Accessions | Q9NUG6 ENST00000202017.6 |